Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma
- Written by ACN Newswire - Press Releases
Read more //?#
.
Controlling business spend is helping finance leaders to forecast with confidence
Forecasting has always been central to financial planning; however, traditional methods based on historical trends are no longer enough. Economic ...
From correction to resilience: making the most of Australia’s evolving insurance landscape
Australia is benefiting from one of the most favourable insurance market environments seen in years. However, it’s important to recognise that these...
AI is Changing Trademarking Forever
The launch of ChatGPT in 2022 marked a turning point for AI. In three short years, AI has been integrated into everything from our phone cameras to ...
Times Media Australia Launches Times Australia Today
A New National Digital Publication Designed to Make Sense of Modern Australia Sydney, Australia — 26 November 2025 — Times Media Australia today an...
The Future of Ozi.com.au
Ozi.com.au: The New Benchmark in Australian Digital Services In a digital landscape evolving at breakneck speed, Australian businesses are demand...
Brisbane’s brightest recognised: Daniel Mikus and James Rolph win Specialist Services Award at the 2025 Brisbane Young Entrepreneur Awards - again
Young Brisbane entrepreneurs Daniel Mikus and James Rolph, cofounders of MR Group, have been officially crowned winners of the Specialist Services...